Allakos Statistics
Total Valuation
Razor Labs has a market cap or net worth of ILS 184.48 million. The enterprise value is 151.17 million.
Market Cap | 184.48M |
Enterprise Value | 151.17M |
Important Dates
The last earnings date was Monday, August 11, 2025.
Earnings Date | Aug 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Razor Labs has 39.36 million shares outstanding. The number of shares has increased by 1.15% in one year.
Current Share Class | 39.36M |
Shares Outstanding | 39.36M |
Shares Change (YoY) | +1.15% |
Shares Change (QoQ) | +1.29% |
Owned by Insiders (%) | 78.07% |
Owned by Institutions (%) | 2.35% |
Float | 8.63M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.62 |
PB Ratio | 58.34 |
P/TBV Ratio | 58.75 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -9.11 |
EV / Sales | 5.42 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -22.41 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 1.55.
Current Ratio | 1.51 |
Quick Ratio | 1.44 |
Debt / Equity | 1.55 |
Debt / EBITDA | n/a |
Debt / FCF | -0.72 |
Interest Coverage | -7.84 |
Financial Efficiency
Return on equity (ROE) is -152.26% and return on invested capital (ROIC) is -47.30%.
Return on Equity (ROE) | -152.26% |
Return on Assets (ROA) | -15.60% |
Return on Invested Capital (ROIC) | -47.30% |
Return on Capital Employed (ROCE) | -63.75% |
Revenue Per Employee | 679,756 |
Profits Per Employee | -404,780 |
Employee Count | 41 |
Asset Turnover | 0.43 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Razor Labs has paid 49,000 in taxes.
Income Tax | 49,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.19% in the last 52 weeks. The beta is 2.12, so Razor Labs's price volatility has been higher than the market average.
Beta (5Y) | 2.12 |
52-Week Price Change | +31.19% |
50-Day Moving Average | 468.40 |
200-Day Moving Average | 496.31 |
Relative Strength Index (RSI) | 46.86 |
Average Volume (20 Days) | 69,521 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Razor Labs had revenue of ILS 27.87 million and -16.60 million in losses. Loss per share was -0.42.
Revenue | 27.87M |
Gross Profit | 12.17M |
Operating Income | -16.08M |
Pretax Income | -16.55M |
Net Income | -16.60M |
EBITDA | -15.51M |
EBIT | -16.08M |
Loss Per Share | -0.42 |
Balance Sheet
The company has 38.22 million in cash and 4.89 million in debt, giving a net cash position of 33.33 million or 0.85 per share.
Cash & Cash Equivalents | 38.22M |
Total Debt | 4.89M |
Net Cash | 33.33M |
Net Cash Per Share | 0.85 |
Equity (Book Value) | 3.16M |
Book Value Per Share | 0.08 |
Working Capital | 15.55M |
Cash Flow
In the last 12 months, operating cash flow was -6.51 million and capital expenditures -240,000, giving a free cash flow of -6.75 million.
Operating Cash Flow | -6.51M |
Capital Expenditures | -240,000 |
Free Cash Flow | -6.75M |
FCF Per Share | -0.17 |
Margins
Gross margin is 43.66%, with operating and profit margins of -57.71% and -59.55%.
Gross Margin | 43.66% |
Operating Margin | -57.71% |
Pretax Margin | -59.38% |
Profit Margin | -59.55% |
EBITDA Margin | -55.67% |
EBIT Margin | -57.71% |
FCF Margin | n/a |
Dividends & Yields
Razor Labs does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.15% |
Shareholder Yield | n/a |
Earnings Yield | -9.00% |
FCF Yield | -3.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |